HAI
GSK icon

Hennessy Advisors Inc’s GSK GSK Stock Holding History

Hennessy Advisors Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Sell
122,460
-2,300
-2% -$122K 0.21% 143
2026
Q1 		$6.89M Sell
124,760
-27,900
-18% -$1.51M 0.25% 126
2025
Q4 		$7.49M Sell
152,660
-8,500
-5% -$396K 0.27% 113
2025
Q3 		$6.96M Sell
161,160
-2,500
-2% -$97.7K 0.24% 122
2025
Q2 		$6.28M Hold
163,660
– – 0.21% 135
2025
Q1 		$6.34M Buy
163,660
+39,100
+31% +$1.43M 0.21% 125
2024
Q4 		$4.21M Sell
124,560
-4,500
-3% -$162K 0.13% 162
2024
Q3 		$5.28M Hold
129,060
– – 0.17% 146
2024
Q2 		$4.97M Sell
129,060
-2,600
-2% -$109K 0.19% 148
2024
Q1 		$5.64M Sell
131,660
-4,100
-3% -$169K 0.24% 102
2023
Q4 		$5.03M Buy
+135,760
New +$4.87M 0.25% 108
2022
Q2 		– Sell
-110,960
Closed -$6.04M – 292
2022
Q1 		$6.04M Buy
110,960
+4,720
+4% +$256K 0.32% 110
2021
Q4 		$5.86M Sell
106,240
-2,400
-2% -$125K 0.33% 102
2021
Q3 		$5.19M Sell
108,640
-1,760
-2% -$88.4K 0.31% 108
2021
Q2 		$5.5M Hold
110,400
– – 0.31% 103
2021
Q1 		$4.92M Buy
110,400
+25,120
+29% +$1.14M 0.29% 117
2020
Q4 		$3.92M Sell
85,280
-5,040
-6% -$232K 0.25% 118
2020
Q3 		$4.25M Sell
90,320
-2,080
-2% -$104K 0.3% 101
2020
Q2 		$4.71M Sell
92,400
-1,680
-2% -$86.2K 0.33% 92
2020
Q1 		$4.46M Buy
94,080
+1,040
+1% +$55.5K 0.33% 86
2019
Q4 		$5.46M Sell
93,040
-4,400
-5% -$245K 0.28% 103
2019
Q3 		$5.2M Sell
97,440
-2,640
-3% -$136K 0.26% 101
2019
Q2 		$5.01M Hold
100,080
– – 0.24% 116
2019
Q1 		$5.23M Sell
100,080
-19,840
-17% -$991K 0.24% 106
2018
Q4 		$5.73M Sell
119,920
-4,240
-3% -$209K 0.28% 92
2018
Q3 		$6.23M Hold
124,160
– – 0.23% 103
2018
Q2 		$6.26M Hold
124,160
– – 0.21% 107
2018
Q1 		$6.06M Buy
124,160
+23,840
+24% +$1.11M 0.2% 102
2017
Q4 		$4.45M Hold
100,320
– – 0.14% 162
2017
Q3 		$5.09M Hold
100,320
– – 0.16% 148
2017
Q2 		$5.41M Sell
100,320
-3,520
-3% -$188K 0.17% 118
2017
Q1 		$5.47M Buy
+103,840
New +$5.27M 0.16% 120
2015
Q1 		– Sell
-42,720
Closed -$2.28M – 309
2014
Q4 		$2.28M Hold
42,720
– – 0.06% 247
2014
Q3 		$2.46M Sell
42,720
-1,600
-4% -$98.1K 0.07% 235
2014
Q2 		$2.96M Buy
44,320
+3,920
+10% +$265K 0.09% 226
2014
Q1 		$2.7M Sell
40,400
-3,760
-9% -$254K 0.1% 230
2013
Q4 		$2.95M Sell
44,160
-720
-2% -$46.7K 0.12% 215
2013
Q3 		$2.81M Hold
44,880
– – 0.13% 214
2013
Q2 		$2.8M Buy
+44,880
New +$2.85M 0.14% 192

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Hennessy Advisors Inc's GSK Position: Q2 2026 in Review

Hennessy Advisors Inc reduced its GSK (GSK) stake by 1.8% in Q2 2026, selling an estimated $122K and leaving 122,460 shares worth $6.42M. The position accounts for 0.21% of the portfolio, ranked #143.

Hennessy Advisors Inc first reported a position in GSK in Q2 2013 and has held it in 39 quarters since. The position peaked at $7.49M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Hennessy Advisors Inc held 122,460 shares of GSK worth $6.42M as of Q2 2026.
  • Hennessy Advisors Inc sold 2,300 GSK shares in Q2 2026, an estimated $122K.
  • GSK made up 0.21% of Hennessy Advisors Inc's portfolio in Q2 2026, its #143 holding.
  • Hennessy Advisors Inc first reported a position in GSK in Q2 2013 and has held it in 39 quarters since.
  • Hennessy Advisors Inc's GSK position peaked at $7.49M in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Hennessy Advisors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.